SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-04-000563
Filing Date
2004-02-18
Accepted
2004-02-18 16:36:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 AVANT IMMUNOTHERAPEUTICS, INC. srz9591427v1.txt SC 13G/A 19855
  Complete submission text file 0000902664-04-000563.txt   21945
Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
AVANT IMMUNOTHERAPEUTICS INC (Subject) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-37761 | Film No.: 04613587
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O MILLENNIUM MANAGEMENT LLC 666 FIFTH AVE NEW YORK NY 10103
Business Address C/O MILLENNIUM MANAGEMENT LLC 666 FIFTH AVE NEW YORK NY 10103 2128414000
MILLENNIUM PARTNERS L P (Filed by) CIK: 0000851909 (see all company filings)

IRS No.: 133521699 | Fiscal Year End: 1231